India Brings Pregabalin under Schedule H1 to Curb Misuse and Strengthen Drug Regulation
Union Health Ministry has brought Pregabalin under Schedule H1 to strengthen prescription monitoring, regulate supply chains, and prevent misuse and unauthorised access to the widely used neurological medicine.
Schedule H1 Drug Warning | 25/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy